In a recent MedTech Insight article, Click CEO David Benshoof Klein and CMO Shaheen E Lakhan, MD, PhD, FAAN highlighted Click's strategic priorities, new developments in our pipeline, and the transformative potential of the FDA's latest Prescription Drug Use-Related Software (PDURS) draft guidance on #DigitalTherapeutics. Insights included: - The FDA’s “Prescription Drug Use-Related Software” draft guidance represents a pivotal opportunity for Click, as it helps clarify how combining our software as a medical device (#SaMD) with pharmacotherapy could enable pharma manufacturers to update drug labels with additional clinically meaningful benefit claims. - Leveraging digital interventions to offer personalized treatment not only improves outcomes across various health metrics like cognitive function and cardiovascular risk but also aligns with pharma's evolving demand for tailored solutions, potentially reshaping patient management and payer agreements, particularly in the GLP-1 therapy space. - Click continues to thrive by prioritizing rigorous clinical trials and demonstrating substantial clinical benefits, contrasting with competitors who faced challenges in meeting stakeholder expectations. Read more about Click's approach and our views on the future of digital therapeutics here: https://lnkd.in/epPgkPF9 #DTx #HealthInnovation #MedicalTechnology #ClinicalResearch
About us
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics under development on our platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, cardiology and immunology. Consistently named a best place to work, we foster an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in our mission to provide patients everywhere access to safe and effective prescription digital therapeutics. NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to recruitment@clicktherapeutics.com. Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.
- Website
-
http://www.clicktherapeutics.com
External link for Click Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Digital Therapeutics, Digital Health, Biotechnology, Medical Devices, and Pharmaceuticals
Locations
-
Primary
80 White St
New York, 10013, US
Employees at Click Therapeutics, Inc.
Updates
-
Lydia K., Privacy Manager, is hiring for a Privacy Specialist to join her team! If you or someone you know is interested in this position, please apply directly at the link below or reach out to our Talent Acquisition Partner, Nathan Tran. https://lnkd.in/ecFyqR7c #Hiring #PrivacySpecialist
-
-
The Click Therapeutics team is headed to HLTH Europe 2024! Join us in Amsterdam next week, June 17-20, for an opportunity to meet with Europe's brightest minds in healthcare and to connect with leaders from over 50 countries. Click Therapeutics CEO, David Benshoof Klein is honored to be speaking in the panel "DTx are dead - long live DTx!" on Tuesday, June 18th at 2:40 PM at the Startup Stage. To request a meeting regarding partnership opportunities, please contact bd@clicktherapeutics.com #HLTH #HLTHEurope #DigitalHealth #Healthcare #HealthTech
-
-
Click Therapeutics will be attending the American Headache Society's 66th Annual Scientific Meeting on Thursday, June 13! Stop by our booth (#415) to learn more on the future of migraine treatment. Our prescription digital therapeutic in development, CT-132, recently completed two Phase 3 clinical studies for prevention of episodic migraine (ReMMi-D and ReMMiD-C), in support of a de novo classification registration with FDA. CT-132 previously received Breakthrough Device Designation from FDA. Our team, led by Click’s Chief Medical Officer Shaheen E Lakhan, MD, PhD, FAAN Lakhan along with Timothy Peters-Strickland, Mariya Petrova, LMHC, PhD, Laura Taraboanta, and Alex Kuka, PhD, is looking forward to connecting with fellow neurologists and other physicians, scientists, and all health professionals dedicated to caring for patients with migraine. Learn more: https://lnkd.in/eJF6q89i #AHSAM24 #MigraineManagement #AmericanHeadacheSociety #DigitalTherapeutics
-
-
Click Therapeutics is excited to share our participation at the 2024 Digital Therapeutics Alliance Summit, taking place in Washington, D.C. this week! Catch members of the Click team at the #2024DTASummit sharing expertise and insights on prescription digital therapeutics (#PDTs) during panels on Thursday and Friday. See the full agenda here: https://lnkd.in/eHKcCPMy Tony McDermott Puneet Sodhi Rich DeNunzio #DTA #DTx #DigitalHealth #MedTech
-
-
This past weekend, our Click colleagues, partners, family, and friends joined together for the NAMI walks in NYC, Miami, and Boston, demonstrating our dedication to mental health advocacy. We were proud to stand with NAMI and our local communities to inspire hope and recovery. Today, on World Schizophrenia Day, we recognize the millions of people and loved ones who are impacted by this condition. As Mental Health Awareness Month draws to a close, let's continue the dialogue and work towards breaking the stigma associated with mental illness. #NAMIWalks2024 #MentalHealthMatters #EndTheStigma #MentalHealthAwarenessMonth #WorldSchizophreniaDay #NAMI
-
-
Click Therapeutics, Inc. reposted this
✨About last night’s Women in Life Sciences Happy Hour✨ When we started planning this event, our main goal was to ensure everyone left with new knowledge or a meaningful connection (dare I say a new friend!). We weren't certain - would people be interested in coming to an event like this? Do we need to have a panel to make it compelling? And on and on. We ultimately decided to keep it simple and try our luck. We were so humbled by the level of interest we got in this event, hundreds of registrations, in the short few weeks we had the invitation open for. It quickly exceeded our expectations, and with that the capacity for the event venue - which we've taken a note on for next time! What struck me the most was the genuine warmth in the room and the power to support, uplift and advance that comes with that. It was clear that despite the vastness of new york city and the multitude of organizations and activities, there are so many that are still seeking community and thoughtful spaces to build deeper connections. We hope that is something we can offer as, after last night, we will most certainly be continuing with this event series. A huge thank you to everyone who came out, old friends and new. We hope you enjoyed it as much as we did 💚 Thank you to Kiara Honma and Jonni Mills for your thoughtful planning and execution 👏 P.S. we've created a linkedin community here to keep the conversation goin' 😉 Join here: https://lnkd.in/eZ6JZ_5H
-
-
-
-
-
+1
-
-
Congratulations to Dr. Theodore “Ted” Pak on receiving the Massachusetts Medical Society’s 2024 Information Technology Award! Dr. Pak’s winning project, “Massive mining of clinical notes with large language models to improve antibiotic choice for sepsis,” showcases the necessary innovation that drives progress in healthcare. By harnessing the power of large language models (LLMs) and clinical informatics, he has created a potential application to improve antibiotic selection for sepsis. At Click Therapeutics, Inc., we are honored to sponsor this award and support initiatives that advance patient care through digital innovation. We look forward to witnessing the continued impact of Dr. Pak’s work in the medical field. Learn more on Dr. Pak’s submission: https://lnkd.in/e-AdcwQ8 #DigitalInnovation #AIinHealthcare #DigitalHealth #LargeLanguageModels #ClinicalInformatics
-
Click Therapeutics is excited to announce the acquisition of the assets of Better Therapeutics. We look forward to building upon the work of the Better Therapeutics team as we advance our pipeline in obesity and cardiometabolic disease. Initial efforts will focus on adapting AspyreRx to Click’s AI-enabled platform and optimizing it for co-prescription with anti-obesity and diabetes medications such as GLP-1s, with the goal of improving treatment persistence, outcomes, and value. We are eager to leverage this acquisition to drive meaningful advancements in patient care. Read the full release: https://lnkd.in/eq93hve4 #CardiometabolicDisease #ObesityManagement #PrescriptionDigitalTherapeutics #GLP1
-
-
We're thrilled to welcome eleven talented individuals to the Click Therapeutics team for our Summer 2024 Internship Program! These interns will spend the next eleven weeks gaining invaluable hands-on experience, contributing directly to the development of our digital treatments, and participating in weekly learning and development sessions to expand their knowledge and skills. Thank you for choosing Click Therapeutics to kickstart your career journeys! We look forward to the fresh perspectives and contributions you will bring to our team. Nistar Steinerman, Cyber Security Intern (Brandeis University, Class of 2026) Ilan Falcon, Machine Learning Engineer Intern (Columbia University, Class of 2025) Gideon Marcus, Business Development Intern (Columbia University, Class of 2025) Sara Lok, SaMD Quality Intern (Cornell University, Class of 2025) Laila Dancy, UX Research Intern (Cornell University, Class of 2025) Lauren Jun, Design Intern (Cornell University, 2025) Julia Freitag, Data Privacy Intern (Harvard University, Class of 2025) Berkan Yesilyurt, Accounting Intern (Rutgers University, 2026) Aanika Patel, Corporate Strategy Intern (University of Michigan, Class of 2025) Allison Xiao, Discovery Science Intern (University of Pennsylvania, Class of 2025) Arav Nangia, Alliance Management & External Innovation Intern (University of Pennsylvania, Class of 2026) #InternshipProgram #SummerInternship #DigitalTherapeutics
-